Skip to main content
. 2021 Feb 20;10(4):874. doi: 10.3390/jcm10040874

Figure 2.

Figure 2

Progression of pulmonary function test results at the end of follow-up in patients with RA and ILD receiving DMARDs. * p-value for the comparison between 24 months and baseline; ^ p-value for the comparison between end of follow-up and baseline.